MentionFox
Home › Who owns › Lixte Biotechnology Holdings Inc
Owners, funding and legal record

Who owns Lixte Biotechnology Holdings Inc? Owners, funding and legal record

The most recent 5%+ ownership report on Lixte Biotechnology Holdings Inc names Vanguard Capital Management holding 5.02% (Schedule 13G, filed 2026-07-31).

About to sign with, pay or invest in Lixte Biotechnology Holdings Inc? See the free Snapshot first.

Free to see. No signup.

Before you sign or pay

Who is behind it

Lixte Biotechnology Holdings Inc: incorporated in Delaware; business address in Boca Raton, Florida; industry Pharmaceutical Preparations (Schedule 13G, 2026-07-31).

Officers and directors, each with the role and the filing that names them:

ReportHolderShare
Schedule 13G, 2026-07-31Vanguard Capital Management5.02%
Schedule 13G, 2026-06-09Strategic Ep, LLC5.1%
FiledPersonRoleChangeEffective
Form 8-K, 2026-07-02John Travagliniappointed
Form 8-K, 2026-06-01Stuart D. PorterDirectorappointed2026-05-29

Money raised

FiledSoldOffered
Form D, 2023-08-01$3.50M$3.50M

Latest IPO step: Lixte Biotechnology Holdings Inc amended its IPO registration (S-1/A, 2025-07-10).

IPO filings: S-1/A, 2025-07-10, S-1/A, 2025-06-24, S-1, 2025-06-18, 424B4, 2025-04-11, S-1/A, 2025-04-09; ticker LIXT on Nasdaq Capital Market.

Acquisitions reported on Form 8-K, Item 2.01: completed an acquisition (2026-07-02); completed an acquisition (2025-11-25).

Related pages

Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.

Not for employment, credit, insurance or tenancy decisions.

Cite this page

Permanent URL: https://mentionfox.com/who-owns/lixte-biotechnology
Last updated 2026-10-18
Who owns Lixte Biotechnology Holdings Inc? Owners, funding and legal record. MentionFox, 2026-10-18. https://mentionfox.com/who-owns/lixte-biotechnology